Nevirapine
- Product NDC
- 65162-209
- 11-digit product format
- 651620209
- Labeler code
- 65162
- Product ID
- 65162-209_fd384f73-fd86-4750-8d30-ecbb4289572a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nevirapine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals LLC
- Application
- ANDA078195
- Marketing category
- ANDA
- Marketing start
- 2014-04-30
- Substance
- NEVIRAPINE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Nevirapine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| NEVIRAPINE | 200 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 99DK7FVK1H |
| Rxcui | 199422 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 65162-209-06 | Nevirapine | 60 in 1 BOTTLE | TABLET | 60 | | 10 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| NEVIRAPINE | ACTIVE INGREDIENT | 99DK7FVK1H | NEVIRAPINE TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 4 | |
| NEVIRAPINE | ACTIVE MOIETY | 99DK7FVK1H | NEVIRAPINE TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 4 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | NEVIRAPINE TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 4 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | NEVIRAPINE TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 4 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | NEVIRAPINE TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 4 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | NEVIRAPINE TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 4 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | NEVIRAPINE TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 4 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | NEVIRAPINE TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 4 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | NEVIRAPINE TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 4 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 65162-209 | NEVIRAPINE TABLET [AMNEAL PHARMACEUTICALS LLC] | 10 | Current NDC, Legacy NDC, 1 package rows | 20241031_4f065674-4719-4c79-ba0d-549040d77f17.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 65162-209-06 | 65162020906 | 60 TABLET in 1 BOTTLE (65162-209-06) | 60 tablet | 2014-04-30 | 0000-00-00 | No | No | Current |